Diagnostic News and Research

RSS

Astute Medical completes $26.5 million series B financing

Astute Medical, Inc., a developer of novel, biomarker-based medical diagnostics, today announced completion of a $26.5 million series B financing co-led by Domain Associates and Delphi Ventures. Astute will use the funding to advance research and development aimed at the identification and validation of protein biomarkers with the goal of commercializing high potential diagnostic products.

10 May 2010

Radnet first-quarter revenue down, net loss up

RadNet, Inc., a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 190 fully-owned and operated outpatient imaging centers, today reported financial results for its first quarter of 2010.

10 May 2010

Negative impact of depression on glycemic control in type 2 diabetes patients

In this German prospective representative study of patients with type 2 diabetes, baseline depression predicted problems with medication adherence, problems with health-related behaviors, and unsatisfactory glycemic control at follow-up.

10 May 2010

CE 3D US creates spatial view for hemodynamic and morphologic evaluation of focal liver tumors

Recently, contrast-enhanced (CE) ultrasound (US) appeared as an important modality to show the vascularity in the areas of interest, and has been used widely in clinical diagnosis of liver lesions. Three dimensional ultrasonography (3D US) allows three orthogonal planes to spatially demonstrate the features of subjects, which has been frequently used in fetal US.

10 May 2010

$Free online fracture-risk calculator$

Free online fracture-risk calculator

FRAX- is a free online fracture-risk calculator (http://www.shef.ac.uk/FRAX/) that has been developed by the World Health Organization Collaborating Centre for Metabolic Bone Diseases at the University of Sheffield, UK. More and more physicians around the world are using the tool as an aid in making informed treatment decisions in the course of a clinical assessment of their patients.

10 May 2010

Novel imaging techniques improve post heart attack survival rates in mouse model

Human adult stem cells injected around the damage caused by a heart attack survived in the heart and improved its pumping efficiency for a year in a mouse model, researchers at The University of Texas MD Anderson Cancer Center report online ahead of publication in Circulation Research.

10 May 2010

Guidance on selection of POCT devices based on patient care setting, clinical needs

Clinical and Laboratory Standards Institute recently published "Selection Criteria for Point-of-Care Testing Devices; Approved Guideline". This document provides guidance on selection of point-of-care testing devices based on the patient care setting and clinical needs.

7 May 2010

NewCardio to unveil patented CardioBip technology at HRS Annual Scientific Sessions

NewCardio, Inc., a cardiac diagnostic technology provider, will unveil its patented CardioBip technology for remote wireless 12-lead detection and monitoring of atrial fibrillation, ischemia and other cardiovascular events at the Heart Rhythm Society 31st Annual Scientific Sessions, May 12-15, 2010, in Denver, Colorado.

7 May 2010

Telemedical Retinal Image Analysis and Diagnosis technology permits early detection of diabetic retinopathy

Automated Medical Diagnostics, a startup company based in Memphis, envisions its product helping to preserve the sight of millions of people at risk of vision loss from diabetic retinopathy.

7 May 2010

Gene patenting policies affect patient access to testing for disease-causing genes: Study

Policies allowing genes to be patented can make it more difficult for patients to access testing for important disease-causing gene mutations, according to a series of papers in a special online supplement published by Genetics in Medicine, the official peer-reviewed journal of The American College of Medical Genetics.

7 May 2010

$CT technique is more specific than X-rays in detecting thoracic, lumbar spine fractures: Study$

CT technique is more specific than X-rays in detecting thoracic, lumbar spine fractures: Study

When trauma patients receive a computed tomography scan of the chest, abdomen, and pelvis, a technique called CT spine reformatting eliminates the need for X-rays of the thoracic and/or lumbar spine to detect spinal fractures. This technique can lower cost and overall patient radiation exposure, according to a study to be presented at the ARRS 2010 Annual Meeting in San Diego, CA.

7 May 2010

Roche launches cobas(R) 4800 System in Canada for testing CT, NG and HPV

Roche Diagnostics Canada announced today the launch of a new Health Canada approved clinical laboratory system designed to increase laboratory testing efficiency and to accommodate current and long-term molecular diagnostic needs. The cobas(R) 4800 System combines in vitro diagnostic tests for Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG) and human papillomavirus (HPV) testing with fully-automated sample preparation and real-time polymerase chain reaction (PCR) technology.

From Roche Sequencing and Life Science 7 May 2010

New CD4 test kit can improve quality of life for HIV and AIDS patients

The use of rapid point-of-care diagnostic tests for the measurement of CD4 T-cells, a marker of the immune system will be an important factor in improving the lives of people living with HIV and AIDS especially in developing and resource-poor countries.

7 May 2010

DXA testing can prevent osteoporosis in at-risk women

Geisinger has exceeded the national benchmark for testing women who are at risk for developing osteoporosis - a silent and serious disease.

7 May 2010

VA plans to limit surgeries at some of its facilities

The Department of Veterans Affairs will limit the kinds of surgeries at some hospitals after a review of surgical deaths at a hospital in southern Illinois, The Associated Press reports. "Under a new system, the VA has given each hospital a 'surgical complexity' level. Because of that, hospitals in at least five states — Louisiana, West Virginia, North Carolina, Illinois and Washington state — will now only perform less-complicated surgeries. The VA will pick up the tab for patients who have surgeries performed elsewhere" (Hefling, 5/6).

7 May 2010

Genzyme to initiate $2 billion stock buyback

Genzyme Corp. today announced that its Board of Directors has voted to pursue several actions to increase shareholder value. The company will initiate a $2 billion stock buyback, under which $1 billion of stock will be repurchased in the near term and financed with debt. The additional $1 billion of stock will be repurchased during the next 12 months.

7 May 2010

Series Three of Percepta's Gene Expression Profiling Life Science Dashboard market research report

Percepta Associates Inc. announces the release of Series Three of its Gene Expression Profiling Life Science Dashboard market research report. Unique to the Percepta report, Series Three offers comparisons to the findings of Series One (February 2007) and Series Two (April 2008).

6 May 2010

TechniScan granted U.S. patent for methods in creating diagnostic images from complex wave fields

TechniScan, Inc., the developer of a revolutionary 3-D breast imaging system, announced today the grant of U.S. Patent 7,684,846, which provides additional intellectual property protection for proprietary methods in creating diagnostic images from complex wave fields.

6 May 2010

NanoString Technologies receives ISO 13485:2003 certification

NanoString Technologies, Inc., a privately held life sciences company marketing a complete solution for detecting and counting large sets of target molecules in biological samples, today announced it has received ISO 13485:2003 certification, an internationally recognized quality standard for medical devices.

From NanoString Technologies 6 May 2010

Xience V sales out-performing Promus in Japanese drug-eluting stent market: MRG

According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, when Abbott Vascular's Xience V and Boston Scientific's Promus entered the Japanese drug-eluting stent market in Q1 2010, both companies picked up share from competitors Medtronic and Cordis.

6 May 2010

Diagnostic News and Research

Astute Medical completes $26.5 million series B financing

Radnet first-quarter revenue down, net loss up

Negative impact of depression on glycemic control in type 2 diabetes patients

CE 3D US creates spatial view for hemodynamic and morphologic evaluation of focal liver tumors

Free online fracture-risk calculator

Novel imaging techniques improve post heart attack survival rates in mouse model

Guidance on selection of POCT devices based on patient care setting, clinical needs

NewCardio to unveil patented CardioBip technology at HRS Annual Scientific Sessions

Telemedical Retinal Image Analysis and Diagnosis technology permits early detection of diabetic retinopathy

Gene patenting policies affect patient access to testing for disease-causing genes: Study

CT technique is more specific than X-rays in detecting thoracic, lumbar spine fractures: Study

Roche launches cobas(R) 4800 System in Canada for testing CT, NG and HPV

New CD4 test kit can improve quality of life for HIV and AIDS patients

DXA testing can prevent osteoporosis in at-risk women

VA plans to limit surgeries at some of its facilities

Genzyme to initiate $2 billion stock buyback

Series Three of Percepta's Gene Expression Profiling Life Science Dashboard market research report

TechniScan granted U.S. patent for methods in creating diagnostic images from complex wave fields

NanoString Technologies receives ISO 13485:2003 certification

Xience V sales out-performing Promus in Japanese drug-eluting stent market: MRG

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News